S
300501
vs
S
Shanghai Composite
Over the past 12 months, Shanghai Haishun New Pharmaceutical Packaging Co Ltd has underperformed Shanghai Composite, delivering a return of +6% compared to the Shanghai Composite's +23% growth.
Stocks Performance
300501 vs Shanghai Composite
Performance Gap
300501 vs Shanghai Composite
Performance By Year
300501 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Shanghai Haishun New Pharmaceutical Packaging Co Ltd
Glance View
Shanghai Haishun New Pharmaceutical Packaging Co., Ltd. engages in the research, development, production, and sale of pharmaceutical packaging materials. The company is headquartered in Shanghai, Shanghai and currently employs 688 full-time employees. The company went IPO on 2016-02-04. The firm's major products include cold-forming composite hard sheet, polyterephthalate (PTP) aluminum foil and suppository (SP) films. Other products include polytrifluorochloroethylene (PTFCE) and polyvinyl chloride (PVC) composite hard sheet. Its products are widely used in the packaging of pharmaceutical, such as tablets, pills, capsules, granules, powders and suppositories, among others.
